Needle-free GHK-Cu can live on the face, the scalp, or in one daily oral-dissolve step. The 3% cream has the closest human skin evidence, the 0.5% or 3% solution puts copper-peptide biology directly on the scalp, and the troche is the simplest object to administer.
Current Rebody pricing: the available 3% GHK-Cu cream is $99 for the first month, then $214.99 per 30 g pump. Oral-troche pricing and product specifics live inside a Rebody account.
The short answer
Needle avoidance does not force one alternative. Rebody's non-injectable GHK-Cu family includes an available refrigerated face-and-neck cream, coming-soon scalp solutions, and an oral troche with specifics inside Rebody.
Choose by the target and the routine. For visible facial renewal, choose cream. For scalp and hair, choose solution. For the fewest application steps, choose the troche and keep its route-matched evidence scope in view.
Needle-free formats at a glance
| Product | Strength | Package | Routine | Evidence advantage |
|---|---|---|---|---|
| GHK-Cu cream | 3% | 30 g pump | Face/neck; refrigerated | Available at $99 first month, then $214.99 |
| GHK-Cu scalp solution | 0.5% | 50 mL bottle | Scalp; refrigerated | Coming soon |
| GHK-Cu scalp solution | 3% | 50 mL bottle | Scalp; refrigerated | Coming soon; higher concentration not proven better |
| GHK-Cu oral troche | See Rebody account | See Rebody account | Oral dissolve | No clinical outcome advantage established |
Injection is absent from the routine, but each remaining form still has instructions, storage, side effects, and evidence limits.
Needle-free does not mean route-free
A cream, solution, and troche expose different tissues. Topicals rely on contact with skin or scalp and the behavior of their vehicle. A troche relies on dissolution, mouth contact, swallowing, and whatever systemic exposure the finished formula produces.
No valid conversion lets a customer compare a topical percentage with an oral amount numerically. The units and routes are different. An oral-dissolve format also does not prove complete or rapid absorption.
Needle-free describes the routine, not equivalent results across routes. Cream, scalp solution, and troche still differ in target, evidence, storage, and daily use.
Best for visible facial skin: cream
The 3% GHK-Cu acetate cream comes in a 30 g airless pump and requires refrigeration. The closest human evidence used topical facial creams over 12 weeks and measured firmness, laxity, density, thickness, wrinkles, pigmentation, and texture.
That makes cream the strongest non-injectable skin choice. It has a defined application surface and a human evidence lane. Final amount, frequency, and days of supply remain label facts.
Choose it when an at-home facial cream is acceptable and refrigerator storage is easy enough to repeat.
Best for scalp: solution
The scalp bottle contains GHK-Cu in 0.5% or 3% strength and a 50 mL topical format. It avoids needles and avoids applying a heavy face cream through hair.
The hair evidence is much thinner than the skin evidence. A related AHK-Cu peptide was tested in isolated follicles, while a GHK-Cu microemulsion was tested in mice. Human regrowth from the planned bottles is not established.
Choose solution for its target and ingredient, not because GHK-Cu has beaten minoxidil. No human evidence establishes either planned concentration as the better starting strength.
Best for avoiding topical application: troche
The GHK-Cu acetate troche is an oral-dissolve product. Exact formulation, package, and directions live inside the Rebody account.
It removes skin spreading, scalp parting, pumps, and residue. That makes administration physically simple. Oral storage, package, price, and refill details are not public.
The troche makes GHK-Cu compact and easy to administer. Human route-matched trials have not yet established whole-body cosmetic, hair, recovery, or longevity outcomes for this formulation.
What the research says by form
Topical GHK-Cu skin research includes small human studies. It also includes substantial cell, tissue, animal, and mechanism work. That combination provides a credible but modest cosmetic evidence base.
Scalp research includes related-peptide follicle experiments and animal delivery work. It supports investigation, not a patient regrowth promise.
Oral-troche evidence is mechanism-led. Reviews of GHK-Cu biology do not establish absorption or clinical results for the finished oral formulation. This ranking is therefore decisive: cream first for evidence, scalp solution first for target, troche first only for administration simplicity.
Daily actions and friction
Cream requires clean application, pump handling, and refrigerator return. Scalp solution requires parting hair, reaching skin, allowing the formula to settle or dry, and managing styling. Troche requires correct oral placement and uninterrupted dissolve time according to its final instructions.
Travel magnifies the difference. Topicals need a cold plan. Troche storage is not confirmed, so do not assume it can live in a room-temperature pill case.
Describe these actions on the product card. “Needle-free” by itself hides the work that remains.
Application and missed-use questions
Use each product's label for amount, frequency, placement, and missed use. Do not borrow drop counts, pump counts, dissolve minutes, food restrictions, or doubled-dose instructions from another formula.
Do not mix topicals together, move cream to scalp, or apply scalp solution to face. Do not chew or swallow a troche immediately when the intended placement is sublingual or buccal.
A product that runs out early may reflect technique or an incorrect assumed amount. Resolve the cause rather than stretching or diluting the remainder.
Storage and travel
Cream and scalp solutions are refrigerated. Keep labels attached, avoid freezing, and prevent direct gel-pack contact. Ask about permitted room-temperature time before leaving home.
Troche storage requires written confirmation. Its small package may be easier to carry, but that does not settle temperature needs.
For any format, check a broken seal, leak, separation, particles, strong odor change, damaged troches, or moisture exposure before continuing. Do not use blue color as a quality test.
Side effects by route
Topicals can produce redness, burning, itching, scaling, swelling, hives, acne-like bumps, or dermatitis. A scalp formula can affect hair feel and residue. A cream can feel occlusive.
Troches can produce mouth irritation, taste complaints, altered sensation, or gastrointestinal issues. Exact systemic safety questions require the final product guidance because topical studies cannot answer them.
Seek prompt help for breathing difficulty, facial or tongue swelling, spreading hives, blistering, severe eye symptoms, or signs of infection.
Cost and supply
The available cream is $99 first month, then $214.99 per 30 g pump. Hair-solution prices are not public, while troche pricing stays inside the Rebody account. Package size alone cannot establish days of supply.
Compare total package price, expected duration, storage, shipping, and refill cadence once available. The simplest route can cost more; a larger package can last less time; cold shipping can change the real month.
Hold any “best value” award until these facts are current.
Questions people ask
Is topical GHK-Cu as good as injection?
That head-to-head clinical comparison has not been established. For skin, topical has the advantage of relevant human cosmetic studies and local application.
Do oral troches work?
No human route-matched outcome trial establishes skin, hair, recovery, or longevity benefits for the finished oral troche.
Which form is easiest?
The troche removes topical application. The cream and scalp solution make the target more obvious and have closer route evidence.
Which form is best for hair?
Use the scalp solution for a GHK-Cu hair routine. Human regrowth remains unproven, and minoxidil has stronger evidence.
Which form is best for wrinkles?
The 3% cream is the GHK-Cu form aligned with small human facial studies.
Bottom line
Needle-free GHK-Cu gives each goal a clear form. Cream wins for visible skin renewal and human topical evidence. Solution wins for direct scalp targeting. Troche wins for the simplest physical routine. Choose the product whose target, evidence, and ownership rhythm match what you want to change.
Keep reading
- Daily GHK-Cu Formats for Home: Troche, Cream, or Scalp Bottle
- GHK-Cu by Route: Oral Troche, Skin Cream, and Scalp Solution
- Oral GHK-Cu vs Topical GHK-Cu: Topical Has the Human Skin Evidence